Literature DB >> 23246262

Number-needed-to-vaccinate calculations: fallacies associated with exclusion of transmission.

Ashleigh R Tuite1, David N Fisman.   

Abstract

BACKGROUND: Number-needed-to-vaccinate (NNV) calculations are used with increasing frequency as metrics of the attractiveness of vaccination programs. However, such calculations as typically applied consider only the direct protective effects of vaccination and ignore indirect effects generated through reduction of force of infection (i.e., risk of infection in susceptible individuals). We postulated that such calculations could produce profoundly biased estimates of vaccine attractiveness.
METHODS: We used mathematical models simulating endemic and epidemic diseases with a variety of epidemiological characteristics, and in the face of varying approaches to immunization, to evaluate biases associated with exclusion of transmission. We generated number-needed-to-vaccinate calculations using both traditional methods, and using a more realistic approach that defines this quantity as the ratio of cases prevented through vaccination (directly or indirectly) to individuals vaccinated. We quantified bias as the ratio of estimates produced using these two different methods.
RESULTS: Across a range of simulated infectious diseases with variable epidemiological characteristics, and in the context of both pulsed vaccination and ongoing vaccine programs, traditional NNV calculations based on systems using plausible infectious disease parameters produced estimates biased by up to 3 orders of magnitude (i.e., 1000 fold). Unbiased NNV estimates were seen only in the context of diseases with extremely high reproductive numbers that could be prevented with highly efficacious vaccines.
CONCLUSIONS: When evaluated using mathematical models that simulate common vaccine-preventable diseases of public health importance, typical number-needed-to-vaccinate calculation produce marked over-estimates relative to NNV calculations incorporating the fundamental transmissibility of communicable diseases. NNV calculations should be used with caution and interpreted critically when used as metrics for the potential community-level impact of vaccination programs.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23246262     DOI: 10.1016/j.vaccine.2012.11.097

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Number Needed to Quarantine and Proportion of Prevented Infectious Days by Quarantine: Evaluating the Effectiveness of COVID-19 Contact Tracing.

Authors:  Diogo Fernandes da Silva; João Vasco Santos; Filipa Santos Martins
Journal:  Public Health Rep       Date:  2022-08-20       Impact factor: 3.117

2.  Number needed to immunize to prevent RSV with extended half-life monoclonal antibody.

Authors:  Lyn Finelli; Yoonyoung Choi; Edward Goldstein
Journal:  Vaccine       Date:  2020-06-26       Impact factor: 3.641

3.  The Hybrid Incidence Susceptible-Transmissible-Removed Model for Pandemics : Scaling Time to Predict an Epidemic's Population Density Dependent Temporal Propagation.

Authors:  Ryan Lester Benjamin
Journal:  Acta Biotheor       Date:  2022-01-29       Impact factor: 1.185

4.  The role of pediatricians as key stakeholders in influencing immunization policy decisions for the introduction of meningitis B vaccine in Canada: The Ontario perspective.

Authors:  Hirotaka Yamashiro; Nora Cutcliffe; Simon Dobson; David Fisman; Ronald Gold
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Jul-Aug       Impact factor: 2.471

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.